Cargando…
Adverse effects of BCG vaccine 1173 P2 in Iran: A meta-analysis
Although in the last two decades the World Health Organization (WHO) has introduced tuberculosis as “a threat to global”, the vaccination with the Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is the only way for the prevention of this fatal infectious disease. Despite of the efficacy of BCG va...
Autores principales: | Mostaan, Saied, Yazdanpanah, Bahador, Moukhah, Rasool, Hozouri, Hamid Reza, Rostami, Manouchehr, Khorashadizadeh, Mohsen, Zerehsaz, Javad, Mahabadi, Ramin Pirhajati, Saadi, Arya, Khanahmad, Hossein, Pooya, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918213/ https://www.ncbi.nlm.nih.gov/pubmed/27376038 http://dx.doi.org/10.4103/2277-9175.183659 |
Ejemplares similares
-
The effect of in vitro consecutive passages and culture medium on the genetic variations in BCG Pasteur 1173P2 vaccine
por: Asadian, Mahla, et al.
Publicado: (2023) -
Genomic characteristics of two most widely used BCG vaccine strains: Danish 1331 and Pasteur 1173P2
por: Asadian, Mahla, et al.
Publicado: (2022) -
Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma
por: Doroud, Delaram, et al.
Publicado: (2022) -
Preparation of monoclonal antibodies against mannosylated lipoarabinomannan (ManLAM), a surface antigen of BCG vaccine produced in Iran
por: Taghikhani, Mohammad, et al.
Publicado: (2016) -
Challenges to Improve the Stability and Efficacy of an Intravesical BCG Product
por: Hozouri, Hamidreza, et al.
Publicado: (2014)